PharmaCyte Biotech | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%)等
02/15 04:45
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%)等
02/06 23:01
PharmaCyte Biotech | 3:首次持股声明-股东 PharmaCyte Biotech, Inc.
2023/11/29 06:06
PharmaCyte Biotech | 4:持股变动声明-董事 WEINSTEIN ROBERT
2023/11/23 06:02
PharmaCyte Biotech | 4:持股变动声明-董事 WALKER WAYNE REMELL
2023/11/23 06:02
PharmaCyte Biotech | 4:持股变动声明-首席财务官 Trujillo Carlos
2023/11/23 06:01
PharmaCyte Biotech | 4:持股变动声明-高管 Silverman Joshua
2023/11/23 06:01
PharmaCyte Biotech | 4:持股变动声明-董事 SCHECHTER JONATHAN
2023/11/23 06:01
PharmaCyte Biotech | 4:持股变动声明-董事 Abecassis Michael M
2023/11/23 06:00
PharmaCyte Biotech | SC 13D:超过5%持股股东披露文件-PharmaCyte Biotech, Inc.(37.0%)
2023/11/23 05:00
PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%)等
2023/06/17 05:22
PharmaCyte Biotech | SC 13G:超过5%持股股东披露文件-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%)等
2023/05/20 05:19
PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%)等
2023/05/13 04:22
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Shay Capital LLC(0.00%),Shay Capital Holdings LLC(0.00%)
2023/02/15 05:30
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)-Daniel B. Asher(9.99%),Mitchell P. Kopin(8.4%)等
2023/02/08 19:05
PharmaCyte Biotech | SC 13G/A:超过5%持股股东披露文件(修正)
2023/01/11 00:57
PharmaCyte Biotech | 3:首次持股声明-董事 WALKER WAYNE REMELL
2022/12/31 05:06
PharmaCyte Biotech | 4:持股变动声明
2022/12/31 05:05
PharmaCyte Biotech | 4:持股变动声明
2022/12/31 05:05
PharmaCyte Biotech | 3:首次持股声明-董事 WEINSTEIN ROBERT
2022/11/17 05:12
暂无数据
暂无数据